Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.
3.

Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.

Weinstein L.

Obstet Gynecol. 1987 Jun;69(6):929-32.

PMID:
3574823
4.

Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.

McGonigle KF, Karlan BY, Barbuto DA, Leuchter RS, Lagasse LD, Judd HL.

Gynecol Oncol. 1994 Oct;55(1):126-32.

PMID:
7959253
5.

Estrogen-progestin replacement therapy and endometrial cancer.

Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM.

J Natl Cancer Inst. 1997 Aug 6;89(15):1110-6.

PMID:
9262248
6.
7.

The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.

Barrett-Connor E, Slone S, Greendale G, Kritz-Silverstein D, Espeland M, Johnson SR, Waclawiw M, Fineberg SE.

Maturitas. 1997 Jul;27(3):261-74.

PMID:
9288699
8.

Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.

Palacios S, Currie H, Mikkola TS, Dragon E.

Maturitas. 2015 Apr;80(4):435-40. doi: 10.1016/j.maturitas.2015.01.003. Epub 2015 Jan 24. Review.

PMID:
25684082
9.

Effects of estrogen plus progestin on health-related quality of life.

Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG; Women's Health Initiative Investigators.

N Engl J Med. 2003 May 8;348(19):1839-54. Epub 2003 Mar 17.

10.

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.

Koh KK, Mincemoyer R, Bui MN, Csako G, Pucino F, Guetta V, Waclawiw M, Cannon RO 3rd.

N Engl J Med. 1997 Mar 6;336(10):683-90.

11.

Cause-specific mortality in women receiving hormone replacement therapy.

Schairer C, Adami HO, Hoover R, Persson I.

Epidemiology. 1997 Jan;8(1):59-65.

PMID:
9116097
12.

Risk of endometrial cancer following estrogen replacement with and without progestins.

Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergström R, Lindgren A, Correia N, Persson I.

J Natl Cancer Inst. 1999 Jul 7;91(13):1131-7.

PMID:
10393721
13.
14.

Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer.

Jick SS, Hagberg KW, Kaye JA, Jick H.

Obstet Gynecol. 2009 Jan;113(1):74-80. doi: 10.1097/AOG.0b013e31818fdde4.

PMID:
19104362
17.

Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.

MacLennan AH, MacLennan A, Wenzel S, Chambers HM, Eckert K.

Med J Aust. 1993 Jul 19;159(2):102-6.

PMID:
8336583
18.
19.

Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.

Skouby SO, Gram J, Andersen LF, Sidelmann J, Petersen KR, Jespersen J.

Am J Obstet Gynecol. 2002 May;186(5):969-77.

PMID:
12015523
20.

HRT dosing regimens: continuous versus cyclic-pros and cons.

Shoupe D.

Int J Fertil Womens Med. 2001 Jan-Feb;46(1):7-15. Review.

PMID:
11294619

Supplemental Content

Support Center